Cargando…

Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease

Through a targeted recruitment 23andMe has collected DNA and patient-reported symptoms from more than 10,000 subjects reporting a physician-verified diagnosis of PD. This study evaluated the potential of self-report, web-based questionnaires to rapidly assess disease natural history and symptomology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winslow, Ashley R., Hyde, Craig L., Wilk, Jemma B., Eriksson, Nicholas, Cannon, Paul, Miller, Melissa R., Hirst, Warren D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113219/ https://www.ncbi.nlm.nih.gov/pubmed/30154511 http://dx.doi.org/10.1038/s41598-018-30843-6

Ejemplares similares

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
por: De Waele, Ségolène, et al.
Publicado: (2022)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Clinically relevant connectivity features define three subtypes of Parkinson's disease patients
por: Guo, Tao, et al.
Publicado: (2020)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary tale
por: Wilk, Jemma B, et al.
Publicado: (2007)

Identification of the Gene Expression Rules That Define the Subtypes in Glioma
por: Cai, Yu-Dong, et al.
Publicado: (2018)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
por: Oliveira, Luis M. A., et al.
Publicado: (2021)

IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes
por: Brown, Eric L., et al.
Publicado: (2023)

The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
por: Booth, Heather D.E., et al.
Publicado: (2017)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
por: Bantle, Collin M., et al.
Publicado: (2021)

Uncertainties in the PET defined A‐/T(Neocortical)+ subtype
por: Mormino, Elizabeth C., et al.
Publicado: (2022)

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent
por: Hyde, Craig L., et al.
Publicado: (2016)

Defining Ourselves: Personal Bioinformation as a Tool of Narrative Self-Conception
por: Postan, Emily
Publicado: (2016)

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
por: Ursin, G, et al.
Publicado: (2005)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Is there a subtype of developmental Parkinson's disease?
por: Riederer, P.
Publicado: (2003)

PrimerHunter: a primer design tool for PCR-based virus subtype identification
por: Duitama, Jorge, et al.
Publicado: (2009)

Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015)

DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Genetically Defined Subtypes of Somatostatin-Containing Cortical Interneurons
por: Hostetler, Rachel E., et al.
Publicado: (2023)

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
por: Zhang, Fan, et al.
Publicado: (2023)

Genetically Defined Subtypes of Somatostatin-Containing Cortical Interneurons
por: Hostetler, Rachel E., et al.
Publicado: (2023)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer
por: Collins, Kyla A.L., et al.
Publicado: (2018)

Defining Young in the Context of Prostate Cancer
por: Chambers, Suzanne K., et al.
Publicado: (2015)

Prediction of mechanistic subtypes of Parkinson’s using patient-derived stem cell models
por: D’Sa, Karishma, et al.
Publicado: (2023)

Embarrassment and Shame in People With Parkinson's Disease: A New Tool for Self-Assessment
por: Fleury, Vanessa, et al.
Publicado: (2020)

Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
por: Barretina, Jordi, et al.
Publicado: (2010)

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia
por: Moorman, A V, et al.
Publicado: (2002)

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
por: Marziali, G., et al.
Publicado: (2016)

Dietary Factors in the Etiology of Parkinson's Disease
por: Agim, Zeynep S., et al.
Publicado: (2015)

Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales
por: Siddiqui, Muhammed R S, et al.
Publicado: (2016)

EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma
por: Lucas, Calixto-Hope G., et al.
Publicado: (2021)

Falls in Parkinson’s Disease Subtypes: Risk Factors, Locations and Circumstances
por: Pelicioni, Paulo H. S., et al.
Publicado: (2019)

Defining a role for hemoglobin in Parkinson’s disease
por: Freed, James, et al.
Publicado: (2016)

Defining the unknowns for cell therapies in Parkinson's disease
por: Lane, Emma L., et al.
Publicado: (2022)

Patient-Specific Data Fusion Defines Prognostic Cancer Subtypes
por: Yuan, Yinyin, et al.
Publicado: (2011)

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
por: Jabbari, Ali, et al.
Publicado: (2016)

Correction: DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_228palvd971odsc9k3u48k1vv2